Epidemiología del COVID-19 en América Latina

Nancy Doris Calzada-Gonzales; Maribel Jessica Calzada-Gonzales

doi:10.37711/rpcs.2020.2.2.126

Authors

Nancy Doris Calzada-Gonzales Clínica Odontológica Nueva Imagen, Huánuco, Perú.
Maribel Jessica Calzada-Gonzales Universidad de Huánuco,Huánuco, Perú

DOI:

https://doi.org/10.37711/rpcs.2020.2.2.126

Keywords:

severe acute respiratory syndrome, COVID-19, coronavirus, quarantine, angiotensin converting enzyme 2, Peptidyl dipeptidase A., Latin America, public health, human body, severe acute respiratory syndrome, coronavirus infections, China, disease outbreaks

Abstract

Severe acute respiratory syndrome (SARS), is caused by coronavirus (SARS-CoV-2). It uses the angiotensin-converting enzyme 2 receptor (ACE2) to invade human bodies. In December 2019, an unprecedented outbreak of pneumonia of unknown etiology emerged in Wuhan City, Hubei Province of China. The outbreak was reported to the WHO on December 31, 2019, who on February 11 named it COVID-19. Latin America was no exception to this public health problem. On February 25, 2020, the Brazilian Department of Health confirmed the first confirmed case of a 61-year-old Brazilian man. Currently, despite rigorous global containment and quarantine efforts, the incidence of COVID-19 continues to rise, with 3,435,894 laboratory confirmed cases and more than 239,000 deaths worldwide. In response to this global outbreak, we will conduct an epidemiology review regarding Latin American.